uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted September 13, 2013

Metagenics Warned For Misbranding of Medical Foods and Drug Claims

On August 13, 2013, the FDA issued a warning letter to Metagenics, Inc., following a review of the company's website, which found UltraClear, UltraClear Plus, UltraClear Plus pH, UltraClear RENEW, GI Sustain, UltraMeal Plus, UltraMeal Plus 360, UltraInflamX, UltraInflamX Plus 360, UltraGlycemX, GlycemX 360, Ultracare for Kids, BariatrX Essentials Bariatric Meal, and ArginCor to be improperly promoted as medical foods. The FDA found that these products do not meet federal regulations for medical foods because the conditions for which they are promoted do not have "distinctive nutritional requirements" that "cannot be met through dietary modification alone."

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at